Details of the National Institutes of Health-funded study were published this week in a Nature paper titled A brain reward circuit inhibited by next-generation weight-loss drugs in mice. In it, the team reported that they investigated the small-molecule GLP-1s including Eli Lillys recently approved drug orforglipron, also known by the brand name Foundayo, as well as danuglipron, an oral GLP-1 that was being developed by Pfizer until the company decided to discontinue its development in 2025
The focus is on practical lifestyle changes, regular medical check-ups, and proactive health management
Symptoms of hypoglycemia include anxiety, blurred vision, chills, cold sweats, confusion, dizziness, fast heartbeat, headache, increased hunger, nervousness, shakiness, and unusual tiredness or weakness
Heat-stable products like Saccharomyces boulardii and certain shelf-stable multi-strain formulas are more practical for travel than refrigeration-dependent products
One to three cups daily is generally considered safe and may provide metabolic benefits
This is where the answer genuinely depends on individual factors, which is why MEDVi [ built its program around physician-guided selection rather than a one-size-fits-all approach